atenolol has been researched along with Cognition Disorders in 6 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Excerpt | Relevance | Reference |
---|---|---|
" After initial structural MRI and functional positron emission tomography imaging, subjects were randomly assigned in a double-blind fashion for treatment for 1 year with either lisinopril or atenolol." | 5.13 | Brain imaging findings predict blood pressure response to pharmacological treatment. ( Jennings, JR; Meltzer, CC; Muldoon, MF; Price, J; Scanlon, J; Whyte, EM, 2008) |
"Here, we test whether pharmacological treatment of hypertension normalizes regional cerebral blood flow responses and whether it does so differentially according to drug class." | 2.73 | Cerebrovascular support for cognitive processing in hypertensive patients is altered by blood pressure treatment. ( Christie, IC; Jennings, JR; Meltzer, CC; Muldoon, MF; Price, J, 2008) |
"If atenolol was contraindicated, 0." | 2.67 | Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program. ( Applegate, WB; Camel, GH; Greenlick, MR; Hadley, E; Luhr, J; Moye, L; Perry, HM; Pressel, S; Shekelle, RB; Wittes, J, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jennings, JR | 3 |
Muldoon, MF | 3 |
Price, J | 2 |
Christie, IC | 2 |
Meltzer, CC | 3 |
Whyte, EM | 1 |
Scanlon, J | 1 |
Ryan, CM | 1 |
Price, JC | 1 |
Applegate, WB | 1 |
Pressel, S | 1 |
Wittes, J | 1 |
Luhr, J | 1 |
Shekelle, RB | 1 |
Camel, GH | 1 |
Greenlick, MR | 1 |
Hadley, E | 1 |
Moye, L | 1 |
Perry, HM | 1 |
Prince, M | 1 |
Lewis, G | 1 |
Bird, A | 1 |
Blizard, R | 1 |
Mann, A | 1 |
Rogers, TK | 1 |
Bowman, CE | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT00000514] | Phase 3 | 0 participants | Interventional | 1984-06-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
5 trials available for atenolol and Cognition Disorders
Article | Year |
---|---|
Cerebrovascular support for cognitive processing in hypertensive patients is altered by blood pressure treatment.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibi | 2008 |
Brain imaging findings predict blood pressure response to pharmacological treatment.
Topics: Aging; Antihypertensive Agents; Atenolol; Blood Pressure; Brain; Cerebrovascular Circulation; Cognit | 2008 |
Brain function, cognition, and the blood pressure response to pharmacological treatment.
Topics: Antihypertensive Agents; Atenolol; Blood Pressure; Brain; Brain Mapping; Cerebrovascular Circulation | 2010 |
Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the systolic hypertension in the elderly program.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Atenolol; Cerebrovascular Disorders; Chlorthali | 1994 |
A longitudinal study of factors predicting change in cognitive test scores over time, in an older hypertensive population.
Topics: Aged; Amiloride; Antihypertensive Agents; Atenolol; Cognition Disorders; Dementia; Drug Combinations | 1996 |
1 other study available for atenolol and Cognition Disorders
Article | Year |
---|---|
Cognitive impairment associated with beta-blockade in the elderly.
Topics: Aged; Atenolol; Cognition Disorders; Humans; Male; Propranolol | 1990 |